Company Revenue

The company grew in the mid-single digits at constant currency for 3Q22, driven by investments in its commercial channel. ...

The company's reported orthopedic sales grew by nearly 20% in 3Q22, driven by double-digit growth across its product lines....

The company declined in the low-single digits for 3Q22 as Conformis' business model transition meets roadblocks....

The company lowered its 2022 guidance despite nearly 40% growth in 3Q as RSV infections reduce pediatric surgical capacity....

The company grew nearly 45% in 3Q22 on the strength of its new distribution partners and increased surgical volumes....

The company grew in the mid-single digits for 3Q22 when adjusting for currency headwinds and raised its 2022 revenue guidance....

Stryker reported 3Q22 orthopedic sales of $2.26 billion, +4.8% compared to the third quarter of 2021. The company expects inflationary...

The company's 3Q22 orthopedic sales grew in the low double-digits, fueled by the recent acquisitions of In2Bones and Biorez....

The company rebounded nicely in 3Q22 with mid-single digit growth when excluding foreign currency headwinds....

In this edition of our mid-tier player profiles, we focus on three spine players in the top ten that are...